electroCore Inc (ECOR)
5.65
+0.07
(+1.25%)
USD |
NASDAQ |
Apr 25, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
electroCore Cash from Financing (TTM): 7.487M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 7.487M |
September 30, 2023 | 7.487M |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | -0.003M |
June 30, 2022 | 18.76M |
March 31, 2022 | 18.76M |
December 31, 2021 | 25.68M |
September 30, 2021 | 26.04M |
June 30, 2021 | 18.45M |
March 31, 2021 | 25.82M |
December 31, 2020 | 18.90M |
Date | Value |
---|---|
September 30, 2020 | 18.25M |
June 30, 2020 | 7.530M |
March 31, 2020 | 0.1608M |
December 31, 2019 | 0.1608M |
September 30, 2019 | 0.4163M |
June 30, 2019 | -1.561M |
March 31, 2019 | 78.86M |
December 31, 2018 | 78.33M |
September 30, 2018 | 104.16M |
June 30, 2018 | 123.45M |
March 31, 2018 | 57.79M |
December 31, 2017 | 62.49M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.561M
Minimum
Jun 2019
26.04M
Maximum
Sep 2021
10.12M
Average
7.487M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Retractable Technologies Inc | 0.9416M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |